Metabolic drug interactions with newer antipsychotics : A comparative reviewSPINA, Edoardo; DE LEON, Jose.Basic & clinical pharmacology & toxicology (Print). 2007, Vol 100, Num 1, pp 4-22, issn 1742-7835, 19 p.Article

Clinically significant drug interactions with antidepressants in the elderlySPINA, Edoardo; SCORDO, Maria Gabriella.Drugs & aging. 2002, Vol 19, Num 4, pp 299-320, issn 1170-229XArticle

Clobazam Therapeutic Drug Monitoring: A Comprehensive Review of the Literature With Proposals to Improve Future StudiesDE LEON, Jose; SPINA, Edoardo; DIAZ, Francisco J et al.Therapeutic drug monitoring. 2013, Vol 35, Num 1, pp 30-47, issn 0163-4356, 18 p.Article

Clinically Relevant Pharmacokinetic Drug Interactions with Second-Generation Antidepressants : An UpdateSPINA, Edoardo; SANTORO, Vincenza; D'ARRIGO, Concetta et al.Clinical therapeutics. 2008, Vol 30, Num 7, pp 1206-1227, issn 0149-2918, 22 p.Article

Metabolic drug interactions with new psychotropic agentsSPINA, Edoardo; SCORDO, Maria Gabriella; D'ARRIGO, Concetta et al.Fundamental & clinical pharmacology. 2003, Vol 17, Num 5, pp 517-538, issn 0767-3981, 22 p.Article

Determination of risperidone and its major metabolite 9-hydroxyrisperidone in human plasma by reversed-phase liquid chromatography with ultraviolet detectionAVENOSO, Angela; FACCIOLA, Gabriella; SALEMI, Monica et al.Journal of chromatography. B, Biomedical sciences and applications. 2000, Vol 746, Num 2, pp 173-181, issn 1387-2273Article

Are the Safety Profiles of Antipsychotic Drugs Used in Dementia the Same? An Updated Review of Observational StudiesTRIFIRO, Gianluca; SULTANA, Janet; SPINA, Edoardo et al.Drug safety. 2014, Vol 37, Num 7, pp 501-520, issn 0114-5916, 20 p.Article

Clinically Significant Drug Interactions with Newer AntidepressantsSPINA, Edoardo; TRIFIRO, Gianluca; CARACI, Filippo et al.CNS drugs. 2012, Vol 26, Num 1, pp 39-67, issn 1172-7047, 29 p.Article

Determination of olanzapine in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detectionD'ARRIGO, Concetta; MIGLIARDI, Gaetana; SANTORO, Vincenza et al.Therapeutic drug monitoring. 2006, Vol 28, Num 3, pp 388-393, issn 0163-4356, 6 p.Article

ABCB1 Polymorphisms Influence Steady-State Plasma Levels of 9-Hydroxyrisperidone and Risperidone Active MoietyGUNES, Arzu; SPINA, Edoardo; DAHL, Marja-Liisa et al.Therapeutic drug monitoring. 2008, Vol 30, Num 5, pp 628-633, issn 0163-4356, 6 p.Article

Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia : results of a 12-week, double-blind studyOLIE, Jean-Pierre; SPINA, Edoardo; MURRAY, Stephen et al.International clinical psychopharmacology. 2006, Vol 21, Num 3, pp 143-151, issn 0268-1315, 9 p.Article

Further evidence for the association between 5-HT_2C receptor gene polymorphisms and extrapyramidal side effects in male schizophrenic patientsGUNES, Arzu; DAHL, Marja-Liisa; SPINA, Edoardo et al.European journal of clinical pharmacology. 2008, Vol 64, Num 5, pp 477-482, issn 0031-6970, 6 p.Article

Short-term memory loss associated with rosuvastatinGALATTI, Laura; POLIMENI, Giovanni; SALVO, Francesco et al.Pharmacotherapy. 2006, Vol 26, Num 8, pp 1190-1192, issn 0277-0008, 3 p.Article

Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugsSPINA, Edoardo; PERUCCA, Emilio.Epilepsia (Copenhagen). 2002, Vol 43, pp 37-44, issn 0013-9580, SUP2Article

Plasma concentrations of risperidone and 9-hydroxyrisperidone during combined treatment with paroxetineSPINA, Edoardo; AVENOSO, Angela; FACCIOLA, Gabriella et al.Therapeutic drug monitoring. 2001, Vol 23, Num 3, pp 223-227, issn 0163-4356Article

Rabeprazole and psychiatric symptomsPOLIMENI, Giovanni; CUTRONEO, Paola; GALLO, Adele et al.The Annals of pharmacotherapy. 2007, Vol 41, Num 7-8, pp 1315-1317, issn 1060-0280, 3 p.Article

Antipsychotic prescribing pattern among Italian general practitioners : a population-based study during the years 1999-2002TRIFIRO, Gianluca; SPINA, Edoardo; BRIGNOLI, Ovidio et al.European journal of clinical pharmacology. 2005, Vol 61, Num 1, pp 47-53, issn 0031-6970, 7 p.Article

Severe phenytoin intoxication in a subject homozygous for CYP2C9^*3BRANDOLESE, Renato; SCORDO, Maria Gabriella; SPINA, Edoardo et al.Clinical pharmacology and therapeutics. 2001, Vol 70, Num 4, pp 391-394, issn 0009-9236Article

No effect of reboxetine on plasma concentrations of clozapine, risperidone, and their active metabolitesSPINA, Edoardo; AVENOSO, Angela; SCORDO, Maria Gabriella et al.Therapeutic drug monitoring. 2001, Vol 23, Num 6, pp 675-678, issn 0163-4356Article

Effect of Adjunctive Duloxetine on the Plasma Concentrations of Clozapine, Olanzapine, and Risperidone in Patients With Psychotic DisordersSANTORO, Vincenza; D'ARRIGO, Concetta; SPINA, Edoardo et al.Journal of clinical psychopharmacology. 2010, Vol 30, Num 5, pp 634-636, issn 0271-0749, 3 p.Article

Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia : associations with dopamine and serotonin receptor and transporter polymorphismsGIIZEY, Cüneyt; SCORDO, Maria Gabriella; SPINA, Edoardo et al.European journal of clinical pharmacology. 2007, Vol 63, Num 3, pp 233-241, issn 0031-6970, 9 p.Article

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearanceSCORDO, Maria Gabriella; PENGO, Vittorio; SPINA, Edoardo et al.Clinical pharmacology and therapeutics. 2002, Vol 72, Num 6, pp 702-710, issn 0009-9236, 9 p.Article

Different enantioselective 9-hydroxylation of risperidone by the two human CYP2D6 and CYP3A4 enzymesYASUI-FURUKORI, Norio; HIDESTRAND, Mats; SPINA, Edoardo et al.Drug metabolism and disposition. 2001, Vol 29, Num 10, pp 1263-1268, issn 0090-9556Article

Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidoneSCORDO, Maria Gabriella; SPINA, Edoardo; FACCIOLA, Gabriella et al.Psychopharmacologia. 1999, Vol 147, Num 3, pp 300-305, issn 0033-3158Article

Influence of CYP2C9, 2C19 and 2D6 genetic polymorphisms on the steady-state plasma concentrations of the enantiomers of fluoxetine and norfluoxetineSCORDO, Maria G; SPINA, Edoardo; DAHL, Marja-Liisa et al.Basic & clinical pharmacology & toxicology (Print). 2005, Vol 97, Num 5, pp 296-301, issn 1742-7835, 6 p.Article